本页面由Tiger Trade Technology Pte. Ltd.提供服务

Actinium Pharmaceuticals, Inc.

0.9995
-0.0605-5.71%
盘后:0.99950.00000.00%16:10 EDT
成交量:8.75万
成交额:8.90万
市值:3,135.93万
市盈率:2.81
高:1.07
开:1.07
低:0.9955
收:1.06
52周最高:1.74
52周最低:0.7351
股本:3,137.50万
流通股本:3,125.54万
量比:0.52
换手率:0.28%
股息:- -
股息率:- -
每股收益(TTM):0.3559
每股收益(LYR):-1.0900
净资产收益率:45.86%
总资产收益率:11.58%
市净率:1.03
市盈率(LYR):-0.92

数据加载中...

2022/06/29

重要事件披露

8-K - Current report
2022/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/13

重要事件披露

8-K - Current report
2022/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/30

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/20

重要事件披露

8-K - Current report
2020/10/28

重要事件披露

8-K - Current report
2020/10/23

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/14

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]